ProKidney Corp. (PROK) Financials

PROK Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 292.8 million 29.7 million
Dec. 31, 2025 335.6 million 34.8 million
Sept. 30, 2025 351.6 million 33.3 million
June 30, 2025 372.1 million 32.7 million

PROK Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -45.5 million 4.9 million
Dec. 31, 2025 -38.3 million 5.7 million
Sept. 30, 2025 -31.8 million 6.7 million
June 30, 2025 -34.5 million 6.5 million

PROK Net Income

No data available :(

PROK Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 224.9 million - 2.7 million
Dec. 31, 2025 270.0 million - 3.0 million
Sept. 30, 2025 271.7 million - 3.2 million
June 30, 2025 294.7 million - 4.4 million

PROK Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 141.9 million
Dec. 31, 2025 135.0 million
Sept. 30, 2025 135.0 million
June 30, 2025 130.7 million

PROK Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3.8 million 33.8 million 11.3 million -
Dec. 31, 2025 5.8 million 34.2 million 6.3 million -
Sept. 30, 2025 5.2 million 26.8 million 11.9 million -
June 30, 2025 3.1 million 25.9 million 14.0 million -

PROK Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 226000 1.4 million
Dec. 31, 2025 225000 1.4 million
Sept. 30, 2025 217000 1.4 million
June 30, 2025 221000 -

PROK Revenue by Segment

Graph available only for paid members. Upgrade to see it.

PROK

Price: $1.67

52 week price:
0.54
7.13

Earnings Per Share: -0.55 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 602.3 million

Links: